Ftse Mib
38.421,05
0,00%
DAX
22.287,56
-0,24%
S&P 500
6.013,13
-1,71%
NASDAQ
19.524,01
-2,20%
Bitcoin
95.930,31
-0,36%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Europa EU Sanofi (SAN) Sanofi (SAN) Notizie

Sanofi

SAN
104,12
0,00 (0,00%)
24 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: Euronext
Tipo: Azione Ordinaria
Valuta: EUR

Ultime notizie

Data Ora Fonte Titolo
22/2/202508:30UKREGCommuniqué de presse : ECCO 2025 : de nouvelles données sur..
22/2/202508:30UKREGPress Release: ECCO 2025: new duvakitug data reinforce..
22/2/202508:30GLOBEPress Release: ECCO 2025: new duvakitug data reinforce..
22/2/202508:20GLOBETeva and Sanofi Present New Positive Phase 2b Study Results..
19/2/202507:30UKREGPress Release: Sanofi and CD&R sign Opella share purchase..
19/2/202507:30UKREGCommuniqué de presse : Sanofi et CD&R annoncent la signature..
19/2/202507:30GLOBEPress Release: Sanofi and CD&R sign Opella share purchase..
18/2/202507:00UKREGCommuniqué de presse : La FDA accorde un examen prioritaire..
18/2/202507:00GLOBEPress Release: Dupixent sBLA accepted for FDA priority..
18/2/202507:00UKREGPress Release: Dupixent sBLA accepted for FDA priority..
13/2/202520:08GLOBEPress Release: Filing of the 2024 U.S. Form 20-F and French..
13/2/202520:08UKREGCommuniqué de presse : Dépôt du Document d’Enregistrement..
13/2/202520:08UKREGPress Release: Filing of the 2024 U.S. Form 20-F and French..
13/2/202507:00GLOBEPress Release: Update on extraintestinal pathogenic E. coli..
13/2/202507:00UKREGPress Release: Update on extraintestinal pathogenic E. coli..
13/2/202507:00UKREGCommuniqué de presse : Mise à jour sur l’étude clinique de..
07/2/202507:00UKREGCommuniqué de presse : Sanofi annonce la signature d’un..
07/2/202507:00UKREGPress Release: Execution of a share buyback agreement for up..
07/2/202507:00GLOBEPress Release: Execution of a share buyback agreement for up..
03/2/202507:30UKREGPress Release: Sanofi announces buy back of shares from..
03/2/202507:30UKREGCommuniqué de presse : Sanofi annonce un rachat d'actions à..
03/2/202507:30GLOBEPress Release: Sanofi announces buy back of shares from..
31/1/202507:00GLOBEPress Release: Sarclisa is the first anti-CD38 treatment..
30/1/202507:30UKREGCommuniqué de presse : Croissance des ventes de 10,3% au T4...
30/1/202507:30GLOBEPress Release: Q4 sales growth of 10.3%, 2024 business EPS..
30/1/202507:30UKREGPress Release: Q4 sales growth of 10.3%, 2024 business EPS..
29/1/202523:13UKREGSanofi: Informations relatives au nombre de droits de vote..
29/1/202523:13UKREGSanofi: Information concerning the total number of voting..
22/1/202507:00GLOBEPress Release: Sarclisa approved in the EU as the first..
22/1/202507:00UKREGPress Release: Sarclisa approved in the EU as the first..
22/1/202507:00UKREGCommuniqué de presse : Approbation du Sarclisa dans l’UE –..
21/1/202507:00GLOBEPress Release: Opella reaches study milestone for Cialis
21/1/202507:00UKREGCommuniqué de presse : Opella : étape clé franchie pour..
21/1/202507:00UKREGPress Release: Opella reaches study milestone for Cialis
15/1/202518:30UKREGSanofi: Information concerning the total number of voting..
15/1/202518:30UKREGSanofi: Informations relatives au nombre de droits de vote..
13/1/202507:00GLOBEPress Release: Sarclisa obtains first approval in China for..
09/1/202507:00GLOBEPress Release: New Sarclisa subcutaneous formulation met..
09/1/202507:00UKREGPress Release: New Sarclisa subcutaneous formulation met..
09/1/202507:00UKREGCommuniqué de presse : La nouvelle formulation sous-cutanée..
23/12/202407:00UKREGPress Release: Sanofi initiates phase 3 program for PCV21..
23/12/202407:00GLOBEPress Release: Sanofi initiates phase 3 program for PCV21..
23/12/202407:00UKREGCommuniqué de presse : Sanofi lance un programme de phase..
19/12/202418:00UKREGPresse release: Jean-Paul Kress to join Sanofi's Board of..
19/12/202418:00GLOBEPresse release: Jean-Paul Kress to join Sanofi's Board of..
19/12/202418:00UKREGCommuniqué de presse - Jean-Paul Kress rejoint le Conseil..
17/12/202413:30UKREGCommuniqué de presse : Les résultats positifs de phase IIb..
17/12/202413:30UKREGPress Release: Duvakitug positive phase 2b results..
17/12/202413:30GLOBEPress Release: Duvakitug positive phase 2b results..
17/12/202407:30UKREGCommuniqué de presse : Mise en ligne du document « Q4 2024..
Apertura: Min: Max:
Chiusura: 104,12

La tua Cronologia

EU
SAN
Sanofi
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci